Innate Pharma ADR (NASDAQ: IPHA): Stock That Needs Special Handling
The company’s stock has a 5-day price change of 21.88% and 39.66% over the past three months. IPHA shares are trading 27.17% year to date (YTD), with the 12-month market performance down to -8.24% lower. It has a 12-month low price of $1.29 and touched a high of $3.51 over the same period. IPHA has […]
